Briefing
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.
ctDNA in neoadjuvant-treated breast cancer was studied as a reflection of treatment response and survival. The abstract does not name a commercial assay.
- Design: Evidence level 2
- Assay: Not named in the abstract
Annals of OncologyPubMed 33232761DOI 10.1016/j.annonc.2020.11.007